Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchRemdesivirRemdesivir (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Associations between COVID‐19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS‐CoV‐2 variants

Anzalone et al., The Journal of Rural Health, doi:10.1111/jrh.12857
Jul 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality -33% Improvement Relative Risk Ventilation 8% Remdesivir  Anzalone et al.  LATE TREATMENT Is late treatment with remdesivir beneficial for COVID-19? PSM retrospective study in the USA (January 2021 - December 2022) Higher mortality (p<0.0001) and lower ventilation (p<0.0001) c19early.org Anzalone et al., The J. Rural Health, Jul 2024 Favorsremdesivir Favorscontrol 0 0.5 1 1.5 2+
Retrospective 3,018,646 COVID-19 patients in the US showing higher rates of hospitalization, inpatient death, acute kidney injury, major adverse cardiovascular events, and need for mechanical ventilation among rural patients compared to urban patients. The increased risk for rural patients persisted across pre-delta, delta, and omicron variant periods and after adjustments.
Gérard, Zhou, Wu, Kamo, Choi, Kim show significantly increased risk of acute kidney injury with remdesivir.
risk of death, 33.0% higher, HR 1.33, p < 0.001, adjusted per study, propensity score matching, multivariable, day 45.
risk of mechanical ventilation, 8.0% lower, HR 0.92, p < 0.001, adjusted per study, propensity score matching, multivariable, day 45.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Anzalone et al., 2 Jul 2024, retrospective, USA, peer-reviewed, 18 authors, study period 1 January, 2021 - 31 December, 2022. Contact: alfred.anzalone@unmc.edu.
This PaperRemdesivirAll
Associations between COVID‐19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS‐CoV‐2 variants
PhD A Jerrod Anzalone, PhD William H Beasley, Kimberly Murray, MD William B Hillegass, Makayla Schissel, Michael T Vest, Scott A Chapman, PhD Ronald Horswell, MD Lucio Miele, MD J Zachary Porterfield, PhD H Timothy Bunnell, Bradley S Price, MS Sharon Patrick, MD Clifford J Rosen, Susan L Santangelo, MD James C Mcclay, MD Sally L Hodder
The Journal of Rural Health, doi:10.1111/jrh.12857
Purpose: To investigate the enduring disparities in adverse COVID-19 events between urban and rural communities in the United States, focusing on the effects of SARS-CoV-2 vaccination and therapeutic advances on patient outcomes. Methods: Using National COVID Cohort Collaborative (N3C) data from 2021 to 2023, this retrospective cohort study examined COVID-19 hospitalization, inpatient death, and other adverse events. Populations were categorized into urban, urban-adjacent rural (UAR), and nonurban-adjacent rural (NAR). Adjustments included demographics, variant-dominant waves, comorbidities, region, and SARS-CoV-2 treatment and vaccination. Statistical methods included Kaplan-Meier survival estimates, multivariable logistic, and Cox regression.
REVIEW BOARD APPROVALS AND CONSENT TO PARTICIPATE CONFLICT OF INTEREST STATEMENT The authors report no conflict of interest. SUPPORTING INFORMATION Additional supporting information can be found online in the Supporting Information section at the end of this article. How
References
Amstutz, Speich, Mentré, Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials, Lancet Respir Med, doi:10.1016/s2213-2600(22)00528-8
Anderson, 'donoghue, Dechen, Mechanic, Stevens, Uptake of outpatient monoclonal antibody treatments for COVID-19 in the United States: a cross-sectional analysis, J Gen Intern Med, doi:10.1007/s11606-021-07109-5
Anzalone, Horswell, Hendricks, Higher hospitalization and mortality rates among SARS-CoV-2-infected persons in rural America, J Rural Health, doi:10.1111/jrh.12689
Anzalone, Sun, Vinson, Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality: a retrospective cohort study from the National COVID Cohort Collaborative, PLoS One, doi:10.1371/journal.pone.0279968
Benchimol, Smeeth, Guttmann, The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement, PLoS Med, doi:10.1371/journal.pmed.1001885
Bennett, Moffitt, Hajagos, Clinical characterization and prediction of clinical severity of SARS-CoV-2 infection among US adults using data from the US National COVID Cohort Collaborative, JAMA Netw Open, doi:10.1001/jamanetworkopen.2021.16901
Boehmer, Koumans, Skillen, Racial and ethnic disparities in outpatient treatment of COVID-19-United States, January-July 2022, Morb Mortal Wkly Rep
Callaghan, Lueck, Trujillo, Ferdinand, Rural and urban differences in COVID-19 prevention behaviors, J Rural Health, doi:10.1111/jrh.12556
Chan, Hart, Goodman, Geographic access to health care for rural Medicare beneficiaries, J Rural Health Spring, doi:10.1111/j.1748-0361.2006.00022.x
Core, R: A Language and Environment for Statistical Computing
Cuadros, Branscum, Mukandavire, Miller, Mackinnon, Dynamics of the COVID-19 epidemic in urban and rural areas in the United States, Ann Epidemiol, doi:10.1016/j.annepidem.2021.04.007
Cuadros, Moreno, Musuka, Miller, Coule et al., Association between vaccination coverage disparity and the dynamics of the COVID-19 Delta and Omicron waves in the US, Front Med, doi:10.3389/fmed.2022.898101
Cutter, Ash, Emrich, Urban-rural differences in disaster resilience, Ann Am Assoc Geogr
Cyr, Etchin, Guthrie, Benneyan, Access to specialty healthcare in urban versus rural US populations: a systematic literature review, BMC Health Serv Res, doi:10.1186/s12913-019-4815-5
Dobis, Krumel, Sanders, Persistently poor rural counties expelower employment impacts from the coronavirus (COVID-19) pandemic but have higher cumulative COVID-19 case rates
Dong, Du, Gardner, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect Dis, doi:10.1016/s1473-3099(20)30120-1
Douthit, Kiv, Dwolatzky, Biswas, Exposing some important barriers to health care access in the rural USA, Public Health, doi:10.1016/j.puhe.2015.04.001
Esper, Adhikari, Tu, Alpha to Omicron: disease severity and clinical outcomes of major SARS-CoV-2 variants, J Infect Dis, doi:10.1093/infdis/jiac411
Gold, Kelleher, Magid, Dispensing of oral antiviral drugs for treatment of COVID-19 by zip code-level social vulnerability-United States, December 23, 2021, MMWR Morb Mortal Wkly Rep, doi:10.15585/mmwr.mm7125e1
Haendel, Chute, Bennett, The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment, J Am Med Inform Assoc, doi:10.1093/jamia/ocaa196
Hamer, Alasmar, Kwan, Wynia, Ginde et al., Referrals, access, and equity of monoclonal antibodies for outpatient COVID-19: a qualitative study of clinician perspectives, Medicine
Herridge, Azoulay, Outcomes after critical illness, N Engl J Med, doi:10.1056/NEJMra2104669
Hill, Artiga, Rouw, Kates, How Equitable is Access to COVID-19 Treatments
Hill, Artiga, Rouw, Kates, How Equitable is Access to COVID-19 Treatments? Kaiser Family Foundation
Horby, Lim, Emberson, Dexamethasone in hospitalized patients with Covid-19, N Engl J Med, doi:10.1056/NEJMoa2021436
Hudson, Montelpare, Predictors of vaccine hesitancy: implications for COVID-19 public health messaging, Int J Environ Res Public Health, doi:10.3390/ijerph18158054
Inoue, Hatakeyama, Kondo, Post-intensive care syndrome: its pathophysiology, prevention, and future directions, Acute Med Surg, doi:10.1002/ams2.415
Kip, Mccreary, Collins, Evolving real-world effectiveness of monoclonal antibodies for treatment of COVID-19: a cohort study, Ann Intern Med, doi:10.7326/m22-1286
Lamontagne, Agarwal, Rochwerg, A living WHO guideline on drugs for covid-19, BMJ, doi:10.1136/bmj.m3379
Lauring, Tenforde, Chappell, Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study, BMJ, doi:10.1136/bmj-2021-069761
Mackey, Ayers, Kondo, Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths: a system-atic review, Ann Intern Med, doi:10.7326/m20-6306
Melotte, COVID-19 Dashboard for Rural America
Osborne, Physical therapy services for the older persons: barriers to access in rural America, Top Geriatr Rehabil
Peters, Community susceptibility and resiliency to COVID-19 across the Rural-Urban Continuum in the United States, J Rural Health, doi:10.1111/jrh.12477
Quan, Li, Couris, Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries, Am J Epidemiol, doi:10.1093/aje/kwq433
Saelee, Zell, Murthy, Disparities in COVID-19 vaccination coverage between urban and rural counties-United States, December 14, 2020, MMWR Morb Mortal Wkly Rep, doi:10.15585/mmwr.mm7109a2
Shah, Joyce, Plumb, Paxlovid associated with decreased hospitalization rate among adults with COVID-19 -United States, April-September 2022, MMWR Morb Mortal Wkly Rep, doi:10.15585/mmwr.mm7148e2
Strassle, Green, Colbert, Stewart, Nápoles, COVID-19 vaccination willingness and uptake among rural Black/African American, Latino, and White adults, J Rural Health, doi:10.1111/jrh.12751
Sun, Monnat, Rural-urban and within-rural differences in COVID-19 vaccination rates, J Rural Health, doi:10.1111/jrh.12625
Tai, Shah, Doubeni, Sia, Wieland, The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States, Clin Infect Dis, doi:10.1093/cid/ciaa815
Weeks, Shen, Differences in health-related quality of life in rural and urban veterans, Am J Public Health, doi:10.2105/ajph.94.10.1762
Wilcox, Lee, Graves, Jerrod) Anzalone, Manna et al., Details of contributions are available at covid.cd2h.org/core-contributors
{ 'indexed': {'date-parts': [[2024, 7, 3]], 'date-time': '2024-07-03T00:18:53Z', 'timestamp': 1719965933310}, 'reference-count': 55, 'publisher': 'Wiley', 'license': [ { 'start': { 'date-parts': [[2024, 7, 2]], 'date-time': '2024-07-02T00:00:00Z', 'timestamp': 1719878400000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by/4.0/'}], 'funder': [ { 'DOI': '10.13039/100006108', 'name': 'National Center for Advancing Translational Sciences', 'doi-asserted-by': 'publisher'}, { 'DOI': '10.13039/100000057', 'name': 'National Institute of General Medical Sciences', 'doi-asserted-by': 'publisher', 'award': [ 'U54GM104942', 'U54GM115458', 'U54GM104940', 'U54GM133807', 'U54GM115516', 'U54GM115677', 'U54GM104941', 'U54GM115428', 'U54GM104938', 'U54GM138062', 'U54GM128729']}], 'content-domain': {'domain': ['onlinelibrary.wiley.com'], 'crossmark-restriction': True}, 'abstract': '<jats:title>Abstract</jats:title><jats:sec><jats:title>Purpose</jats:title><jats:p>To ' 'investigate the enduring disparities in adverse COVID‐19 events between urban and rural ' 'communities in the United States, focusing on the effects of SARS‐CoV‐2 vaccination and ' 'therapeutic advances on patient ' 'outcomes.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Using National ' 'COVID Cohort Collaborative (N3C) data from 2021 to 2023, this retrospective cohort study ' 'examined COVID‐19 hospitalization, inpatient death, and other adverse events. Populations ' 'were categorized into urban, urban‐adjacent rural (UAR), and nonurban‐adjacent rural (NAR). ' 'Adjustments included demographics, variant‐dominant waves, comorbidities, region, and ' 'SARS‐CoV‐2 treatment and vaccination. Statistical methods included Kaplan‐Meier survival ' 'estimates, multivariable logistic, and Cox ' 'regression.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>The study ' 'included 3,018,646 patients, with rural residents constituting 506,204. These rural dwellers ' 'were older, had more comorbidities, and were less vaccinated than their urban counterparts. ' 'Adjusted analyses revealed higher hospitalization odds in UAR and NAR (aOR 1.07 [1.05–1.08] ' 'and 1.06 [1.03–1.08]), greater inpatient death hazard (aHR 1.30 [1.26–1.35] UAR and 1.37 ' '[1.30–1.45] NAR), and greater risk of other adverse events compared to urban dwellers. Delta ' 'increased, while Omicron decreased, inpatient adverse events relative to pre‐Delta, with ' 'rural disparities persisting throughout. Treatment effectiveness and vaccination were ' 'similarly protective across all cohorts, but dexamethasone post‐ventilation was effective ' 'only in urban areas. Nirmatrelvir/ritonavir and molnupiravir better protected rural residents ' 'against ' 'hospitalization.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Despite ' 'advancements in treatment and vaccinations, disparities in adverse COVID‐19 outcomes persist ' 'between urban and rural communities. The effectiveness of some therapeutic agents appears to ' 'vary based on rurality, suggesting a nuanced relationship between treatment and geographic ' 'location while highlighting the need for targeted rural health care ' 'strategies.</jats:p></jats:sec>', 'DOI': '10.1111/jrh.12857', 'type': 'journal-article', 'created': {'date-parts': [[2024, 7, 2]], 'date-time': '2024-07-02T08:35:07Z', 'timestamp': 1719909307000}, 'update-policy': 'http://dx.doi.org/10.1002/crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Associations between COVID‐19 therapies and outcomes in rural and urban America: A multisite, ' 'temporal analysis from the Alpha to Omicron SARS‐CoV‐2 variants', 'prefix': '10.1111', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-3212-7845', 'authenticated-orcid': False, 'given': 'A. Jerrod', 'family': 'Anzalone', 'sequence': 'first', 'affiliation': [{'name': 'University of Nebraska Medical Center Omaha Nebraska USA'}]}, { 'ORCID': 'http://orcid.org/0000-0002-5613-5006', 'authenticated-orcid': False, 'given': 'William H.', 'family': 'Beasley', 'sequence': 'additional', 'affiliation': [{'name': 'University of Oklahoma Norman Oklahoma USA'}]}, { 'given': 'Kimberly', 'family': 'Murray', 'sequence': 'additional', 'affiliation': [{'name': 'Maine Health Institute for Research Portland Maine USA'}]}, { 'ORCID': 'http://orcid.org/0000-0001-6428-0564', 'authenticated-orcid': False, 'given': 'William B.', 'family': 'Hillegass', 'sequence': 'additional', 'affiliation': [ { 'name': 'University of Mississippi Medical Center Jackson Mississippi ' 'USA'}]}, { 'given': 'Makayla', 'family': 'Schissel', 'sequence': 'additional', 'affiliation': [{'name': 'University of Nebraska Medical Center Omaha Nebraska USA'}]}, { 'ORCID': 'http://orcid.org/0000-0002-3525-6095', 'authenticated-orcid': False, 'given': 'Michael T.', 'family': 'Vest', 'sequence': 'additional', 'affiliation': [{'name': 'Christiana Care Health System Newark Delaware USA'}]}, { 'ORCID': 'http://orcid.org/0000-0002-1594-1554', 'authenticated-orcid': False, 'given': 'Scott A.', 'family': 'Chapman', 'sequence': 'additional', 'affiliation': [ { 'name': 'University of Minnesota College of Pharmacy Minneapolis ' 'Minnesota USA'}]}, { 'ORCID': 'http://orcid.org/0000-0002-7317-7523', 'authenticated-orcid': False, 'given': 'Ronald', 'family': 'Horswell', 'sequence': 'additional', 'affiliation': [ { 'name': 'Louisiana State University Health Sciences Center New Orleans ' 'Louisiana USA'}]}, { 'ORCID': 'http://orcid.org/0000-0002-5853-7287', 'authenticated-orcid': False, 'given': 'Lucio', 'family': 'Miele', 'sequence': 'additional', 'affiliation': [ { 'name': 'Louisiana State University Health Sciences Center New Orleans ' 'Louisiana USA'}]}, { 'ORCID': 'http://orcid.org/0000-0002-2724-9928', 'authenticated-orcid': False, 'given': 'J. Zachary', 'family': 'Porterfield', 'sequence': 'additional', 'affiliation': [{'name': 'University of Kentucky Lexington Kentucky USA'}]}, { 'given': 'H. Timothy', 'family': 'Bunnell', 'sequence': 'additional', 'affiliation': [{'name': "Nemours Children's Health Wilmington Delaware USA"}]}, { 'given': 'Bradley S.', 'family': 'Price', 'sequence': 'additional', 'affiliation': [{'name': 'West Virginia University Morgantown West Virginia USA'}]}, { 'ORCID': 'http://orcid.org/0000-0001-6535-2013', 'authenticated-orcid': False, 'given': 'Sharon', 'family': 'Patrick', 'sequence': 'additional', 'affiliation': [{'name': 'West Virginia University Morgantown West Virginia USA'}]}, { 'ORCID': 'http://orcid.org/0000-0003-3436-8199', 'authenticated-orcid': False, 'given': 'Clifford J.', 'family': 'Rosen', 'sequence': 'additional', 'affiliation': [{'name': 'Maine Health Institute for Research Portland Maine USA'}]}, { 'ORCID': 'http://orcid.org/0000-0001-5576-4495', 'authenticated-orcid': False, 'given': 'Susan L.', 'family': 'Santangelo', 'sequence': 'additional', 'affiliation': [ {'name': 'Maine Health Institute for Research Portland Maine USA'}, {'name': 'Tufts University School of Medicine Boston Massachusetts USA'}]}, { 'ORCID': 'http://orcid.org/0000-0002-3404-0671', 'authenticated-orcid': False, 'given': 'James C.', 'family': 'McClay', 'sequence': 'additional', 'affiliation': [ { 'name': 'University of Missouri School of Medicine Columbia Missouri ' 'USA'}]}, { 'ORCID': 'http://orcid.org/0000-0002-0728-5550', 'authenticated-orcid': False, 'given': 'Sally L.', 'family': 'Hodder', 'sequence': 'additional', 'affiliation': [{'name': 'West Virginia University Morgantown West Virginia USA'}]}, { 'name': 'the National COVID Cohort Collaborative (N3C) Consortium', 'sequence': 'additional', 'affiliation': []}], 'member': '311', 'published-online': {'date-parts': [[2024, 7, 2]]}, 'reference': [ { 'key': 'e_1_2_17_2_1', 'unstructured': 'Centers for Disease Control and Prevention. CDC Museum COVID‐19 ' 'Timeline. 2023. Accessed December 9 ' '2023.https://www.cdc.gov/museum/timeline/covid19.html'}, { 'key': 'e_1_2_17_3_1', 'unstructured': 'COVID Data Tracker. Accessed May 17 ' '2023.https://covid.cdc.gov/covid‐data‐tracker/'}, {'key': 'e_1_2_17_4_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj‐2021‐069761'}, {'key': 'e_1_2_17_5_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/infdis/jiac411'}, { 'key': 'e_1_2_17_6_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.annepidem.2021.04.007'}, {'key': 'e_1_2_17_7_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/jrh.12477'}, {'key': 'e_1_2_17_8_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/jrh.12689'}, { 'key': 'e_1_2_17_9_1', 'unstructured': 'MelotteS.COVID‐19 Dashboard for Rural America.2023. Accessed March 20 ' '2023.https://dailyyonder.com/covid‐19‐dashboard‐for‐rural‐america/'}, {'key': 'e_1_2_17_10_1', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fmed.2022.898101'}, {'key': 'e_1_2_17_11_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/jrh.12751'}, { 'key': 'e_1_2_17_12_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0279968'}, {'key': 'e_1_2_17_13_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/cid/ciaa815'}, {'key': 'e_1_2_17_14_1', 'doi-asserted-by': 'publisher', 'DOI': '10.7326/m20‐6306'}, { 'key': 'e_1_2_17_15_1', 'volume-title': 'Amber Waves: The Economics of Food, Farming, Natural Resources, and ' 'Rural America', 'author': 'Dobis E', 'year': '2022'}, { 'key': 'e_1_2_17_16_1', 'unstructured': 'CDC.Risk for COVID‐19 Infection Hospitalization and Death by ' 'Race/Ethnicity.Centers for Disease Control and Prevention; 2023. ' 'Accessed June 05 2023 ' 'https://www.cdc.gov/coronavirus/2019‐ncov/covid‐data/investigations‐discovery/hospitalization‐death‐by‐race‐ethnicity.html'}, { 'key': 'e_1_2_17_17_1', 'unstructured': 'CDC.COVID‐19 Vaccination Equity. Accessed March 20 2023 ' 'https://covid.cdc.gov/covid‐data‐tracker/#vaccination‐equity'}, {'key': 'e_1_2_17_18_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s12913‐019‐4815‐5'}, { 'key': 'e_1_2_17_19_1', 'unstructured': 'HillL ArtigaS RouwA KatesJ.How Equitable is Access to COVID‐19 ' 'Treatments.Kaiser Family Foundation;2022.'}, { 'key': 'e_1_2_17_20_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1097/MD.0000000000032191'}, { 'key': 'e_1_2_17_21_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s11606‐021‐07109‐5'}, {'key': 'e_1_2_17_22_1', 'doi-asserted-by': 'publisher', 'DOI': '10.15585/mmwr.mm7143a2'}, { 'key': 'e_1_2_17_23_1', 'unstructured': 'National COVID Cohort Collaborative (N3C).N3C Dashboards. Accessed ' 'August 13 2023 https://covid.cd2h.org/dashboard/'}, { 'key': 'e_1_2_17_24_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pmed.1001885'}, {'key': 'e_1_2_17_25_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/jamia/ocaa196'}, { 'key': 'e_1_2_17_26_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jamanetworkopen.2021.16901'}, { 'key': 'e_1_2_17_27_1', 'unstructured': 'Observational Health Data Sciences and Informatics (OHDSI).OMOP CDM ' 'v5.3. Accessed April 7 ' '2023.https://ohdsi.github.io/CommonDataModel/cdm53.html'}, { 'key': 'e_1_2_17_28_1', 'unstructured': 'US Department of Agriculture—Economic Research Service.Rural Urban ' 'Commuting Area Codes. Accessed March 3 ' '2023.https://www.ers.usda.gov/data‐products/rural‐urban‐commuting‐area‐codes/'}, {'key': 'e_1_2_17_29_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/aje/kwq433'}, { 'key': 'e_1_2_17_30_1', 'unstructured': 'COVID Data Tracker: Monitoring Variant Proportions. Accessed August 17 ' '2023.https://covid.cdc.gov/covid‐data‐tracker/#variantproportions'}, { 'key': 'e_1_2_17_31_1', 'unstructured': 'Centers for Disease Control and Prevention. COVID‐19 Treatments and ' 'Medications. 2023. Accessed March 13 2023 ' 'https://www.cdc.gov/coronavirus/2019‐ncov/your‐health/treatments‐for‐severe‐illness.html'}, { 'key': 'e_1_2_17_32_1', 'unstructured': 'R Core Team.R: A Language and Environment for Statistical ' 'Computing.2013.'}, { 'key': 'e_1_2_17_33_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/s1473‐3099(20)30120‐1'}, {'key': 'e_1_2_17_34_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ams2.415'}, {'key': 'e_1_2_17_35_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMra2104669'}, { 'key': 'e_1_2_17_36_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1097/TGR.0b013e31818cd06b'}, { 'key': 'e_1_2_17_37_1', 'unstructured': 'FDA Approves First Treatment for COVID‐19.U.S. Food and Drug ' 'Administration (FDA); 2020. Accessed March 15 ' '2023.https://www.fda.gov/news‐events/press‐announcements/fda‐approves‐first‐treatment‐covid‐19'}, { 'key': 'e_1_2_17_38_1', 'unstructured': 'Fact Sheet for Healthcare Providers: Emergency Use Authorization for ' 'Lagevrio™ (Molnupiravir) Capsules.FDA; 2023. Accessed April 1 2023 ' 'https://www.fda.gov/media/155054/download'}, { 'key': 'e_1_2_17_39_1', 'unstructured': 'Coronavirus (COVID‐19) Update: FDA Authorizes First Oral Antiviral for ' 'Treatment of COVID‐19.U.S. Food and Drug Administration;2021. Accessed ' 'March 15 ' '2023.https://www.fda.gov/news‐events/press‐announcements/coronavirus‐covid‐19‐update‐fda‐authorizes‐first‐oral‐antiviral‐treatment‐covid‐19'}, { 'key': 'e_1_2_17_40_1', 'unstructured': 'Coronavirus (COVID‐19) Update: FDA Authorizes Monoclonal Antibodies for ' 'Treatment of COVID‐19.US Food and Drug Administration;2020. Accessed ' 'March 15 ' '2023.https://www.fda.gov/news‐events/press‐announcements/coronavirus‐covid‐19‐update‐fda‐authorizes‐monoclonal‐antibodies‐treatment‐covid‐19'}, { 'key': 'e_1_2_17_41_1', 'unstructured': 'Coronavirus (COVID‐19) Update: FDA Authorizes Monoclonal Antibody for ' 'Treatment of COVID‐19.US Food and Drug Administration (FDA); 2020. ' 'Accessed March 15 ' '2023.https://www.fda.gov/news‐events/press‐announcements/coronavirus‐covid‐19‐update‐fda‐authorizes‐monoclonal‐antibody‐treatment‐covid‐19#:~:text=Today%2C%20the%20U.S.%20Food%20and ' 'in%20adult%20and%20pediatric%20patients'}, {'key': 'e_1_2_17_42_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.m3379'}, {'key': 'e_1_2_17_43_1', 'doi-asserted-by': 'publisher', 'DOI': '10.15585/mmwr.mm7148e2'}, {'key': 'e_1_2_17_44_1', 'doi-asserted-by': 'publisher', 'DOI': '10.7326/m22‐1286'}, { 'key': 'e_1_2_17_45_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/s2213‐2600(22)00528‐8'}, {'key': 'e_1_2_17_46_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2021436'}, {'key': 'e_1_2_17_47_1', 'doi-asserted-by': 'publisher', 'DOI': '10.15585/mmwr.mm7125e1'}, { 'key': 'e_1_2_17_48_1', 'unstructured': 'HillL ArtigaS RouwA KatesJ.How Equitable is Access to COVID‐19 ' 'Treatments?Kaiser Family Foundation; 2022. Accessed March 13 2023 ' 'https://www.kff.org/coronavirus‐covid‐19/issue‐brief/how‐equitable‐is‐access‐to‐covid‐19‐treatments/'}, { 'key': 'e_1_2_17_49_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.puhe.2015.04.001'}, {'key': 'e_1_2_17_50_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/jrh.12625'}, {'key': 'e_1_2_17_51_1', 'doi-asserted-by': 'publisher', 'DOI': '10.2105/ajph.94.10.1762'}, {'key': 'e_1_2_17_52_1', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ijerph18158054'}, {'key': 'e_1_2_17_53_1', 'doi-asserted-by': 'publisher', 'DOI': '10.15585/mmwr.mm7109a2'}, {'key': 'e_1_2_17_54_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/jrh.12556'}, { 'key': 'e_1_2_17_55_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/24694452.2016.1194740'}, { 'key': 'e_1_2_17_56_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/j.1748‐0361.2006.00022.x'}], 'container-title': 'The Journal of Rural Health', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/jrh.12857', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 7, 2]], 'date-time': '2024-07-02T08:35:20Z', 'timestamp': 1719909320000}, 'score': 1, 'resource': {'primary': {'URL': 'https://onlinelibrary.wiley.com/doi/10.1111/jrh.12857'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 7, 2]]}, 'references-count': 55, 'alternative-id': ['10.1111/jrh.12857'], 'URL': 'http://dx.doi.org/10.1111/jrh.12857', 'relation': {}, 'ISSN': ['0890-765X', '1748-0361'], 'subject': [], 'container-title-short': 'The Journal of Rural Health', 'published': {'date-parts': [[2024, 7, 2]]}, 'assertion': [ { 'value': '2023-09-07', 'order': 0, 'name': 'received', 'label': 'Received', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2024-06-06', 'order': 1, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2024-07-02', 'order': 2, 'name': 'published', 'label': 'Published', 'group': {'name': 'publication_history', 'label': 'Publication History'}}]}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit